ES2199561T3 - Derivados de azatriciclo(3.3.1.1)decano y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de azatriciclo(3.3.1.1)decano y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2199561T3
ES2199561T3 ES99909806T ES99909806T ES2199561T3 ES 2199561 T3 ES2199561 T3 ES 2199561T3 ES 99909806 T ES99909806 T ES 99909806T ES 99909806 T ES99909806 T ES 99909806T ES 2199561 T3 ES2199561 T3 ES 2199561T3
Authority
ES
Spain
Prior art keywords
compound
pyridyl
aza
tricycle
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99909806T
Other languages
English (en)
Spanish (es)
Inventor
Merouane Bencherif
Patrick Michael Lippiello
Peter Anthony Crooks
Haeil Park
Balwinder Singh Bhatti
William Scott Caldwell
Gary Maurice Dull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyre Therapeutics Inc
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/053,937 external-priority patent/US6057446A/en
Priority claimed from US09/054,175 external-priority patent/US5952339A/en
Application filed by Targacept Inc filed Critical Targacept Inc
Application granted granted Critical
Publication of ES2199561T3 publication Critical patent/ES2199561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES99909806T 1998-04-02 1999-03-03 Derivados de azatriciclo(3.3.1.1)decano y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2199561T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/053,937 US6057446A (en) 1998-04-02 1998-04-02 Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US09/054,175 US5952339A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US53937 1998-04-02
US54175 2008-05-19

Publications (1)

Publication Number Publication Date
ES2199561T3 true ES2199561T3 (es) 2004-02-16

Family

ID=26732410

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99909806T Expired - Lifetime ES2199561T3 (es) 1998-04-02 1999-03-03 Derivados de azatriciclo(3.3.1.1)decano y composiciones farmaceuticas que los contienen.

Country Status (13)

Country Link
EP (1) EP1068208B1 (enExample)
JP (1) JP2002510690A (enExample)
KR (1) KR100591805B1 (enExample)
AT (1) ATE240331T1 (enExample)
AU (1) AU2892999A (enExample)
BR (1) BR9907172A (enExample)
CA (1) CA2317567A1 (enExample)
DE (1) DE69907894T2 (enExample)
DK (1) DK1068208T3 (enExample)
ES (1) ES2199561T3 (enExample)
MX (1) MXPA00009634A (enExample)
PT (1) PT1068208E (enExample)
WO (1) WO1999051602A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
MY137020A (en) * 2000-04-27 2008-12-31 Abbott Lab Diazabicyclic central nervous system active agents
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
WO2001082978A2 (en) * 2000-05-01 2001-11-08 Targacept, Inc. Imaging of nicotinic acetylcholine receptor subtypes
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
EP2069346B1 (en) 2007-03-23 2011-12-21 Abbott Laboratories Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
CA2679876A1 (en) * 2007-03-23 2008-10-02 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
CA2809675A1 (en) 2010-09-23 2012-03-29 Shuang Chen Monohydrate of an azaadamantane derivative
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
JP3510937B2 (ja) * 1995-06-05 2004-03-29 ポリプラスチックス株式会社 耐熱性ポリエステルアミドスルフィド樹脂及びその組成物
JPH11508540A (ja) * 1995-06-29 1999-07-27 ノボ ノルディスク アクティーゼルスカブ 新規の置換アザ環式またはアザ二環式化合物
JPH11512443A (ja) * 1995-09-22 1999-10-26 ノボ ノルディスク アクティーゼルスカブ 新規な置換アザ環式またはアザ二環式化合物

Also Published As

Publication number Publication date
DK1068208T3 (da) 2003-09-01
CA2317567A1 (en) 1999-10-14
EP1068208A1 (en) 2001-01-17
WO1999051602A1 (en) 1999-10-14
MXPA00009634A (es) 2005-06-20
BR9907172A (pt) 2000-10-10
PT1068208E (pt) 2003-09-30
EP1068208B1 (en) 2003-05-14
AU2892999A (en) 1999-10-25
ATE240331T1 (de) 2003-05-15
KR20010052173A (ko) 2001-06-25
JP2002510690A (ja) 2002-04-09
KR100591805B1 (ko) 2006-06-26
DE69907894T2 (de) 2004-03-11
DE69907894D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
US5952339A (en) Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
ES2242749T3 (es) Hetoroarildiazabicycloalkanos como ligandos de receptores colinergicos nicotinicos.
US9309234B2 (en) Opioid receptor ligands and methods of using and making same
ES2199561T3 (es) Derivados de azatriciclo(3.3.1.1)decano y composiciones farmaceuticas que los contienen.
US6057446A (en) Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
ES2205778T3 (es) Compuestos azatriciclicos.
ES2214707T3 (es) Derivados de 3-piridil-1-azabicicloalcano para la prevencion y tratamiento de trastornos del snc.
US6624173B1 (en) Pharmaceutical compositions for treating and/or preventing CNS disorders
US6525065B1 (en) Pharmaceutical compositions and methods for effecting dopamine release
US20140045896A1 (en) 1,4-dihydropyridine-3,5-dicarboxylate Derivatives And Preparation And Use Thereof
US6624167B1 (en) Pharmaceutical compositions and methods for use
US6579878B1 (en) Pharmaceutical compositions and methods for use
MXPA00009619A (es) Composiciones farmaceuticas y metodos de uso.
AU2007200621A1 (en) Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands